Literature DB >> 13677406

A heart-healthy and "stroke-free" world through policy development, systems change, and environmental supports: a 2020 vision for sub-Saharan Africa.

George A Mensah1.   

Abstract

The vision of a heart-healthy and "stroke-free" world is achievable through the aggressive prevention and control of cardiovascular risk factors. In sub-Saharan Africa, a region plagued by infectious and parasitic diseases, nutritional deficiencies, and excessive maternal and perinatal morbidity and mortality, the prevention of cardiovascular diseases (CVD) and risk factors is rarely on the public health agenda. In Africa, however, as recently documented by the World Health Organization's Africa Regional Office, CVD and other chronic non-communicable diseases are on the increase and already represent a significant burden on public health services. Age-specific mortality and morbidity associated with CVD and chronic diseases are higher in sub-Saharan Africa than in established market economies. Correspondingly, adverse trends in risk factor profile are beginning to appear especially in many urban centers in sub-Saharan Africa. Addressing and reversing these trends will take more than just targeting individuals and their behaviors and lifestyle choices. More importantly, to support heart-healthy choices, emphasis must be placed on policy development, systems changes, and issues in the social environment factors such as the need to strengthen legislation and regulatory mechanisms, which control the leading risk factors (eg, tobacco, physical inactivity, and poor nutrition). We must develop and conduct heart-healthy and "stroke-free" initiatives to take place in diverse community settings: schools, worksites, communities, and healthcare systems. In addition, public health capacity and infrastructure must be strengthened to provide adequate surveillance and the assurance that best practices are implemented. Action is needed to integrate health promotion, risk factor control and disease prevention within the primary healthcare setting. Above all, population-based approaches must be used to promote education and awareness of the importance of CVD risk factors. In sub-Saharan Africa, where most people have no more than one CVD risk factor, a unique opportunity exists for primordial prevention, ie, preventing the development of risk factors in the first place. The policy and environmental change strategies discussed provide a road map to a heart-healthy and "stroke-free" future.

Entities:  

Mesh:

Year:  2003        PMID: 13677406

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  5 in total

1.  The Association Between Acculturation and Cardiovascular Disease Risk in Ghanaian and Nigerian-born African Immigrants in the United States: The Afro-Cardiac Study.

Authors:  Yvonne Commodore-Mensah; Nwakaego Ukonu; Lisa A Cooper; Charles Agyemang; Cheryl Dennison Himmelfarb
Journal:  J Immigr Minor Health       Date:  2018-10

2.  Anthropometry and cardiovascular disease risk factors among retirees and non-retirees in Ile-Ife, Nigeria: A comparative study.

Authors:  Israel Arogundade Ojo; Jibril Mohammed
Journal:  Niger Med J       Date:  2013-05

3.  Strengthening complex systems for chronic disease prevention: a systematic review.

Authors:  Lori Baugh Littlejohns; Andrew Wilson
Journal:  BMC Public Health       Date:  2019-06-11       Impact factor: 3.295

Review 4.  An estimate of the incidence and prevalence of stroke in Africa: a systematic review and meta-analysis.

Authors:  Davies Adeloye
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

5.  Stroke distribution patterns and characteristics in Kenya's leading public health tertiary institutions: Kenyatta National Hospital and Moi Teaching and Referral Hospital.

Authors:  Lydia Kaduka; Anne Korir; Chrispine Owuor Oduor; Judith Kwasa; Jane Mbui; Sylvanos Wabwire; Robai Gakunga; Nathan Okerosi; Yvonne Opanga; Isaac Kisiang'ani; Mercy Rotich Chepkurui; Erastus Muniu; Scot C Remick
Journal:  Cardiovasc J Afr       Date:  2018 Mar/Apr       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.